Previous randomized controlled trials have demonstrated that a fixed or loose combination of GLP‐1RA and basal insulin significantly reduces HbA1c and body weight in patients with uncontrolled T2D [16]. The gene discussed is INS; the disease is type 2 diabetes mellitus.